BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 953311)

  • 21. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
    Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
    Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.
    Friedman EL; Hayes DF; Kufe DW
    Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to large glycopeptides in sera from patients with ovarian germ cell tumours.
    Kawata M; Higaki K; Sekiya S; Takamizawa H; Muramatsu T; Okumura K
    Clin Exp Immunol; 1983 Feb; 51(2):401-6. PubMed ID: 6301713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification, partial characterization, and clinical evaluation of an adenocarcinoma-associated antigen.
    Pinto VB; Gelder FB; Morris DM
    Cancer Res; 1986 Dec; 46(12 Pt 1):6520-4. PubMed ID: 3536083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of lung adenocarcinoma-associated antigens in human tissues and sera defined by monoclonal antibodies KM-52 and KM-93.
    Shitara K; Hanai N; Yoshida H
    Cancer Res; 1987 Mar; 47(5):1267-72. PubMed ID: 3545444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of the cluster 1 and mucin antigens in human small cell lung cancer and other epithelial tumour cell lines after treatment with the differentiation inducing agent, sodium butyrate.
    Hay FG; Duncan LW; Langdon SP; Leonard RC
    Br J Cancer Suppl; 1991 Jun; 14():33-5. PubMed ID: 1645568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.
    Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T
    Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Determination of leukocyte sensitization to tumor and embryonic tissue antigens in cancer of the large intestine].
    Novikov DK; Shmakov AP
    Vopr Onkol; 1981; 27(8):40-5. PubMed ID: 6269300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential diagnosis between mesotheliomas and metastatic adenocarcinomas using monoclonal antibodies against gastrointestinal carcinoma antigen and stage-specific embryonic antigen.
    Ernst CS; Atkinson B; Chianese D; Peters J; Perry M; Herlyn M; Koprowski H
    Appl Pathol; 1986; 4(3):115-24. PubMed ID: 2885017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initial immunochemical characterization of MX35 ovarian cancer antigen.
    Welshinger M; Yin BW; Lloyd KO
    Gynecol Oncol; 1997 Nov; 67(2):188-92. PubMed ID: 9367706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interspecific embryonic antigens in the blood serum of cancer patients].
    Kalashnikov VV; Chekhonin VP; Tatarinov IuS
    Vopr Onkol; 1983; 29(4):24-9. PubMed ID: 6858045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers].
    Suzumori K; Yasui Y; Asai H; Hisaoka T; Mizuno K; Yagami Y
    Gan No Rinsho; 1985 May; 31(5):544-8. PubMed ID: 3860666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of tumor-associated antigens and their purification for cyst fluids of ovarian epithelial neoplasms.
    Dawson JR; Kutteh WH; Whitesides DB; Gall SA
    Gynecol Oncol; 1980 Aug; 10(1):6-17. PubMed ID: 6772525
    [No Abstract]   [Full Text] [Related]  

  • 34. Purification of human ovarian tumor-associated antigen and demonstration of circulating tumor antigen in patients with advanced ovarian malignancy.
    Knauf S; Urbach GI
    Am J Obstet Gynecol; 1977 Apr; 127(7):705-10. PubMed ID: 66873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunochemical study of the alpha-globulins in human kidney tumor tissue].
    Pchelkina ZM; Matveev BP; Rykunov EI; Terent'ev AA; Tatarinov IuS
    Vopr Med Khim; 1979; 25(4):439-41. PubMed ID: 89757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ovarian cancer: treatment by specific neuraminidase].
    Dodin A; Zylberberg B
    Nouv Presse Med; 1979 Feb; 8(6):437. PubMed ID: 554105
    [No Abstract]   [Full Text] [Related]  

  • 37. Affinity chromatography separation of tumor associated antigens from ascitic fluid of ovarian cancer patients.
    Hill R; Daunter B; Silburn PA; Khoo SK; Mackay EV
    Gynecol Oncol; 1983 Jun; 15(3):428-33. PubMed ID: 6407908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New human embryonic antigen and its presence in some adenocarcinomas.
    Tatarinov YS; Kalashnikov VV
    Nature; 1977 Feb; 265(5595):638-9. PubMed ID: 404557
    [No Abstract]   [Full Text] [Related]  

  • 39. Detection of neoantigens in the serum of patients with active neoplastic diseases by the absorption-immunodiffusion method.
    DeCarvalho S
    Oncology; 1973; 27(3):193-234. PubMed ID: 4634182
    [No Abstract]   [Full Text] [Related]  

  • 40. Human embryonic prealbumin as a marker for tumours and fibroblasts.
    Tatarinov YS; Kalashnikov VV; Vasiliev MY; Voloshuk SG; Kraevsky NA; Vorsanova SG
    Lancet; 1978 Nov; 2(8100):1122-3. PubMed ID: 82683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.